EGLN1 Gene Erythrocytosis, Familial Type 3 Genetic Test

Executive Summary & Core Metrics

Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO‑Certified Next‑Generation Sequencing.
Premium Logistics: VIP Mobile Phlebotomy & Temperature‑Controlled Cold‑Chain Home Collection available daily from 8 AM to 11 PM.
Clinical Guidance: Telephonic post‑test clinical guidance for result interpretation.
Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.

Test Overview & Methodology

The EGLN1 Gene Erythrocytosis, Familial Type 3 Genetic Test detects germline mutations in the EGLN1 gene, which cause primary congenital erythrocytosis. Designed for hematologists, oncologists, and clinical geneticists, this test delivers a definitive molecular diagnosis with industry‑leading turnaround and precision.

Feature	Our Test (NGS)	Closest Alternative
Methodology	Next‑Generation Sequencing (Full Gene Coverage)	Targeted Mutation Panel (Limited Variants)
Analytical Sensitivity	>99.9% for single‑nucleotide variants & indels	~95% (only known hotspots)
Turnaround Time	3–4 Weeks (Rapid Batched Processing)	6–8 Weeks
Clinical Utility	Diagnostic, familial carrier screening, genetic counseling	Often requires reflex to sequencing

Physician Insight & Safety Protocols

“A positive EGLN1 mutation confirms familial erythrocytosis type 3, yet it must be interpreted alongside full blood count, erythropoietin level, and family history. Correlation with clinical phenotype is essential to avoid unnecessary interventions or missed secondary causes.”

— Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403

Advisory

Do not discontinue any prescribed medication or alter your treatment plan before consulting your hematologist. This genetic test does not replace ongoing clinical management.

Safety Exclusion Criteria & Emergency Red Flags

Exclusion: Not intended for acquired polycythemias (e.g., Polycythemia Vera). If JAK2 V617F or CALR mutation screening has not been performed, discuss with your doctor first.
Exclusion: Patients who have received allogeneic hematopoietic stem cell transplant within the last 6 months – donor DNA may confound results.
ER Red Flags: If you experience sudden severe headache, chest pain, shortness of breath, focal neurological deficits, or unilateral leg swelling while awaiting results, seek immediate emergency care.

Patient FAQ & Clinical Guidance

1. How accurate is the EGLN1 Genetic Test for familial erythrocytosis?

The test delivers 99.9% analytical sensitivity for all pathogenic variants in the EGLN1 gene, making it the most definitive diagnostic tool for familial erythrocytosis type 3. Results are validated through Sanger sequencing of any variant with low‑quality scores, ensuring that clinical decisions are based on the highest laboratory standards.

2. What sample types are accepted for the EGLN1 gene test?

A single drop of blood on an FTA card, a standard whole blood tube (EDTA), or previously extracted DNA can be used for the EGLN1 gene test, offering maximum flexibility. Our home collection team brings all material, ensuring proper sample stabilization during cold‑chain transport to the laboratory.

3. Is genetic counseling required before ordering this test in the UAE?

Pre‑genetic counseling is mandatory under UAE Federal Decree‑Law No. 4 of 2016 on Medical Liability, ensuring informed consent and accurate pedigree analysis before EGLN1 testing. Our board‑certified genetic counselors provide a complimentary session to explain the implications for you and at‑risk family members.

UAE Regulatory & Data Privacy Adherence

This service fully complies with Federal Decree‑Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. All genetic data are stored within UAE sovereign clouds. Clinical safety and patient consent align with Federal Decree‑Law No. 4 of 2016 on Medical Liability.

Clinical & Logistical Metadata

Test Name	EGLN1 Gene Erythrocytosis, Familial Type 3 Genetic Test
Price (AED)	2,800
Turnaround Time	3–4 Weeks
Sample Type / Matrix	Whole Blood (EDTA) or FTA Card – VIP Mobile Phlebotomy & Temperature‑Controlled Cold‑Chain Home Collection Available
Methodology Used	Next‑Generation Sequencing (NGS) – Full Gene Coverage
ICD-10-CM Code	D75.0
LOINC Code	55233-1
DHA Facility License & Laboratory Address	DHA License No. 1143, Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE